TransMedics (TMDX) Interest & Investment Income (2018 - 2022)

TransMedics' (TMDX) quarterly Interest & Investment Income came in at $9000.0 in Q2 2022, up 150.0% year-on-year from $3600.0 in Q2 2021, and up 112.33% quarter-over-quarter from -$73000.0 in Q1 2022.

TransMedics (TMDX) Interest & Investment Income (2018 - 2022) Analysis & Trends

TransMedics' Interest & Investment Income history runs 5 years deep, the most recent figure standing at $9000.0 for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 106.00 Mn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn -
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn -
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn -
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 33.50 Mn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn -
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 40.98 Mn
10 TransMedics 2.56 Bn 2.10 Bn 101.16 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 9,000.00
Mar 31, 2022 -73,000.00
Jun 30, 2021 -18,000.00
Mar 31, 2021 8,000.00
Jun 30, 2020 -149,000.00
Mar 31, 2020 213,000.00
Jun 29, 2019 30,000.00
Jun 30, 2018 3,000.00
Mar 31, 2018 4,000.00